LOADING
Comparing Tesla Inc (TSLA) and Johnson & Johnson (JNJ) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | JNJ |
|---|---|---|
| Price | $311.21 | $256.35 |
| Change Today | +0.76% | +0.21% |
| Market Cap | $1.23T | $617.8B |
| P/E Ratio | 285.5 | 29.7 |
| Forward P/E | 158.7 | 22.0 |
| PEG Ratio | 4.56 | 4.22 |
| EPS | $1.09 | $8.64 |
| Revenue Growth (YoY) | 25.5% | 6.6% |
| Profit Margin | 3.7% | 21.5% |
| Return on Equity | 4.7% | 25.7% |
| Dividend Yield | -- | 2.05% |
| Beta | 1.80 | 0.23 |
| 52-Week High | $498.83 | $274.90 |
| 52-Week Low | $297.38 | $162.56 |
| Volume | 36.6M | 6.8M |
Tesla Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.